Development and characterization of human-induced pluripotent stem cell …Nature.comAn evolving understanding of the mechanisms driving biliary development provides the theoretical underpinnings for rational development of induced pluripotent stem cel… Continue reading
Development and characterization of human-induced pluripotent stem cell …Nature.comAn evolving understanding of the mechanisms driving biliary development provides the theoretical underpinnings for rational development of induced pluripotent stem cel… Continue reading
The Australian Financial Review |
Celgene buys into Mesoblast’s stem cell pipeline in regenerative med pact
FierceBiotech Celgene has stepped up with a deal to buy a $45 million chunk of Mesoblast’s stock at a premium price in exchange for a front row seat on the Australian biotech’s stem cell pipeline and a preferred spot at the bargaining table if it follows up with a … Stem cell pioneer lures big pharmaThe Australian Financial Review Shares in this Australian stem cell company are going nuts on an investment …Business Insider Australia Mesoblast Shoots To A 4-Year High On News Of Celgene Corporation Buying …Bidness ETC Sydney Morning Herald –Bloomberg –GlobeNewswire (press release) all 37 news articles » |
The Australian Financial Review |
Celgene buys into Mesoblast’s stem cell pipeline in regenerative med pact
FierceBiotech Celgene has stepped up with a deal to buy a $45 million chunk of Mesoblast’s stock at a premium price in exchange for a front row seat on the Australian biotech’s stem cell pipeline and a preferred spot at the bargaining table if it follows up with a … Stem cell pioneer lures big pharmaThe Australian Financial Review Shares in this Australian stem cell company are going nuts on an investment …Business Insider Australia Mesoblast Shoots To A 4-Year High On News Of Celgene Corporation Buying …Bidness ETC Sydney Morning Herald –Bloomberg –GlobeNewswire (press release) all 37 news articles » |
Brisbane Times |
Shares in this Australian stem cell company are going nuts on an investment …
Business Insider Australia The US company will also get a six-month right of first refusal on Mesoblast’s proprietary adult stem cell product candidates for the prevention and treatment of acute graft versus host disease, certain cancers, inflammatory bowel diseases and organ … Mesoblast Shares Climb as Celgene Invests $45 MillionBloomberg Mesoblast takes partnership with Celgene, shares rise 27pcSydney Morning Herald Celgene And Mesoblast Enter Into Equity Placement and Right of First Refusal …GlobeNewswire (press release) Nasdaq all 22 news articles » |